News > Johnson & Johnson single-shot vaccine 'safe and effective' against Covid-19 infection: FDA
Johnson & Johnson single-shot vaccine 'safe and effective' against Covid-19 infection: FDA
India Today | 24/02/2021 10:34 PM | Click to read full article
J&J said in documents submitted to the FDA that its data suggested its vaccine was effective at preventing asymptomatic infections. It said that in a preliminary analysis of its trial, it found 16 cases of asymptomatic cases in the placebo group versus two in the vaccine group, or an 88% efficacy rate.
The FDA's panel of independent experts meets on Friday to decide whether to approve the shot.